Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00081601 · ClinicalTrials.gov registry record · Phase 2
Study of CEP-701 in Treatment of Prostate Cancer
A Phase 2 study, sponsored by Cephalon.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00081601 is a Phase 2 study that has completed, run by Cephalon. The registered enrollment target is 30 participants.
The verdict
NCT00081601, a Phase 2 study, has completed, sponsored by Cephalon.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the proportion of patients with a serological prostate specific antigen (PSA) by day 85.
Interventions
- DRUG CEP-701
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-03 |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00081601
The ClinicalTrials.gov registry entry for NCT00081601 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cephalon, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CEP-701 is the first listed.
NCT00081601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00081601 about?
NCT00081601 is a clinical study titled "Study of CEP-701 in Treatment of Prostate Cancer". The purpose of this study is to determine the proportion of patients with a serological prostate specific antigen (PSA) by day 85.
What is the current status of trial NCT00081601?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2004-03. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00081601?
The interventions under investigation include: CEP-701 (DRUG).
Who is sponsoring clinical trial NCT00081601?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.